HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J Recall Of Benzene-Tainted Sunscreens Lends Weight To Valisure Claims, Triggers Class Action

Executive Summary

J&J says the recall decision was made out of an abundance of caution, maintaining that daily exposure to benzene at levels detected in J&J sunscreen products “would not be expected to cause adverse health consequences.”

You may also be interested in...



Valisure’s Findings Of Benzene In Body Sprays Suggest Ongoing Aerosol Propellant Problem

Hydrocarbon-based propellants can harbor trace levels of benzene, among other impurities, when quality controls are insufficient. Leading brands’ antiperspirant and deodorant body sprays are the latest aerosol personal-care products identified by independent laboratory Valisure as contaminated with the carcinogen.

US Q3 Consumer Health Earnings Preview: Helm Changes, Supply Challenges, Separation Plan

July-September results for sales of OTC drugs, supplements and personal care products will come with CEO leaving J&J and P&G, a new leader for Perrigo Americas, Bausch Health likely offering Bausch + Lomb separation details and a cloud of rising costs related to supplies.

Coppertone Recalls Benzene-Tainted Sunscreens; Cosmetics Regulatory & Legal News

Consumers can contact Coppertone for refunds for aerosol sunscreens found to contain benzene, a human carcinogen that should not adversely affect users at levels detected, the Beiersdorf brand says. More cosmetics regulatory and legal news in brief.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS151557

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel